Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-25-025997
Filing Date
2025-12-03
Accepted
2025-12-03 17:01:08
Documents
1
Effectiveness Date
2025-12-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10985
  Complete submission text file 0001493152-25-025997.txt   12326
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-565688 | Film No.: 251547235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)